Related Experiment Videos
Chronic vs acute carbamate administration in exercising rats
C B Matthew1, R P Francesconi, W D Bowers
1US Army Res. Inst. Environ. Med., Natick, MA 01760-5007.
Life Sciences
|January 1, 1990
Summary
Chronic physostigmine (PH) administration attenuates exercise decrements and thermoregulatory effects seen with acute PH treatment. This suggests chronic PH may mitigate organophosphate poisoning impacts.
Area of Science:
- Pharmacology
- Toxicology
- Exercise Physiology
Background:
- Organophosphate poisoning is a significant health concern.
- Physostigmine (PH) and pyridostigmine (PY) are carbamates used as antidotes.
- Acute administration of carbamates can impair exercise performance and thermoregulation.
Purpose of the Study:
- To investigate if chronic administration of physostigmine (PH) attenuates the negative effects on endurance and thermoregulation observed with acute PH treatment.
- To compare the effects of acute versus chronic PH administration on exercise capacity and physiological responses in rats.
Main Methods:
- Rats received acute intravenous (iv) physostigmine (PH) or chronic infusion via osmotic mini-pump.
- Groups included control, acute PH (200 ug/kg), chronic PH (7 days), and chronic PH (14 days).
- Exercise testing involved running to exhaustion at a set speed and temperature; heating rates and run times were recorded.
Main Results:
- Acute PH administration significantly decreased endurance and increased heating rates.
- Chronic PH administration (7 and 14 days) attenuated these decremental effects, with 14-day treatment showing near-control performance.
- Ultrastructural changes in diaphragms were less pronounced in chronically treated animals compared to acutely treated ones.
Conclusions:
- Chronic administration of physostigmine (PH) mitigates the adverse effects on exercise performance, thermoregulation, and cellular ultrastructure associated with acute PH exposure.
- These findings suggest a potential therapeutic advantage of chronic PH administration in managing organophosphate poisoning.